(Q37189001)

English

Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorder

scientific article published on January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorder (English)

1 reference

Europe PubMed Central

18 August 2017

attention deficit hyperactivity disorder

0 references

object named as

Rosa Bosch

2

0 references

Josep Antoni Ramos-Quiroga

object named as

Josep Antoni Ramos-Quiroga

1

0 references

author name string

Xavier Castells

3

1 reference

Europe PubMed Central

18 August 2017

Sergi Valero

4

1 reference

Europe PubMed Central

18 August 2017

Mariana Nogueira

5

1 reference

Europe PubMed Central

18 August 2017

Nuria Gómez

6

1 reference

Europe PubMed Central

18 August 2017

Silvia Yelmo

7

1 reference

Europe PubMed Central

18 August 2017

Marc Ferrer

8

1 reference

Europe PubMed Central

18 August 2017

Yolanda Martínez

9

1 reference

Europe PubMed Central

18 August 2017

Miguel Casas

10

1 reference

Europe PubMed Central

18 August 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

22

1 reference

Europe PubMed Central

18 August 2017

7

1 reference

Europe PubMed Central

18 August 2017

603-611

1 reference

Europe PubMed Central

18 August 2017

https://scigraph.springernature.com/pub.10.2165/00023210-200822070-00005

0 references

Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attention-deficit hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is the prevalence of adult ADHD? Results of a population screen of 966 adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A systematic review of the associations between dose regimens and medication compliance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence to Medication

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of adherence measures with different stimulants among children and adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of methylphenidate formulation for attention deficit hyperactivity disorder on patterns and outcomes of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

12-month efficacy and safety of OROS MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of attention-deficit/hyperactivity disorder on employment and household income.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18547128

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00023210-200822070-00005

1 reference

Europe PubMed Central

18 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37189001&oldid=1693460101"